Institute of Virology, University of Duisburg-Essen, University Hospital, Essen, Germany.
Department of Gastroenterology and Hepatology, University of Duisburg-Essen, University Hospital, Essen, Germany.
Hepatology. 2015 Jul;62(1):47-56. doi: 10.1002/hep.27771. Epub 2015 Mar 25.
Activation of hepatitis B virus (HBV)-specific CD8 T cells by therapeutic vaccination may promote sustained control of viral replication by clearance of covalently closed circular DNA from infected hepatocytes. However, little is known about the exact targets of the CD8 T-cell response and whether HBV reproducibly evades CD8 T-cell immune pressure by mutation. The aim of this study was to address if HBV reproducibly selects substitutions in CD8 T-cell epitopes that functionally act as immune escape mutations. The HBV core gene was amplified and sequenced from 148 patients with chronic HBV infection, and the human leukocyte antigen (HLA) class I genotype (A and B loci) was determined. Residues under selection pressure in the presence of particular HLA class I alleles were identified by a statistical approach utilizing the novel analysis package SeqFeatR. With this approach we identified nine residues in HBV core under selection pressure in the presence of 10 different HLA class I alleles. Additional immunological experiments confirmed that seven of the residues were located inside epitopes targeted by patients with chronic HBV infection carrying the relevant HLA class I allele. Consistent with viral escape, the selected substitutions reproducibly impaired recognition by HBV-specific CD8 T cells.
Viral sequence analysis allows identification of HLA class I-restricted epitopes under reproducible selection pressure in HBV core; the possibility of viral escape from CD8 T-cell immune pressure needs attention in the context of therapeutic vaccination against HBV.
治疗性疫苗激活乙型肝炎病毒 (HBV)-特异性 CD8 T 细胞,可能通过清除感染肝细胞中的共价闭合环状 DNA 来促进对病毒复制的持续控制。然而,对于 CD8 T 细胞反应的确切靶点以及 HBV 是否通过突变可重复地逃避 CD8 T 细胞免疫压力,人们知之甚少。本研究旨在探讨 HBV 是否可重复地选择 CD8 T 细胞表位中的取代,这些取代是否具有免疫逃逸突变的功能。从 148 例慢性 HBV 感染患者中扩增和测序 HBV 核心基因,并确定人类白细胞抗原 (HLA) I 类基因型 (A 和 B 基因座)。通过利用新的分析软件包 SeqFeatR 的统计方法,鉴定在特定 HLA I 类等位基因存在下具有选择压力的残基。利用该方法,我们在存在 10 种不同 HLA I 类等位基因的情况下,鉴定出 HBV 核心中的 9 个具有选择压力的残基。额外的免疫实验证实,在携带相关 HLA I 类等位基因的慢性 HBV 感染患者中,有 7 个残基位于被靶向的表位内。与病毒逃逸一致,所选取代物可重复地损害了 HBV 特异性 CD8 T 细胞的识别。
病毒序列分析可鉴定 HBV 核心中具有可重复选择压力的 HLA I 类限制性表位;在针对 HBV 的治疗性疫苗接种背景下,需要注意病毒逃避 CD8 T 细胞免疫压力的可能性。